Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml

Despite prolonged undetectable plasma viral load some HIV-1 infected patients have been reported to develop resistance-associated mutations leading to treatment failure. The mechanisms for this phenomenon and the point of origin for residual viral evolution are still not elucidated. In order to quan...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 79; no. 10; pp. 1440 - 1445
Main Authors Kupfer, Bernd, Matz, Bertfried, Däumer, Martin P, Roden, Fabienne, Rockstroh, Jürgen K, Qurishi, Nazifa, Spengler, Ulrich, Kaiser, Rolf
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.10.2007
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Despite prolonged undetectable plasma viral load some HIV-1 infected patients have been reported to develop resistance-associated mutations leading to treatment failure. The mechanisms for this phenomenon and the point of origin for residual viral evolution are still not elucidated. In order to quantify cell-associated HIV-1 RNA in patients with different levels of plasma viremia paired cell-associated HIV-1 RNA loads and plasma viral loads were determined. Weak inverse correlation between these parameters and the amounts of CD4⁺ T cells was observed, whereas there was no correlation between viral loads and CD8⁺ T cells or CD14⁺ monocytes, respectively. In a subset of patients, cell-associated and plasma HIV-1 env V3 sequences were analyzed. Plasma viral load and the amount of cell-associated HIV-RNA correlated strongly. However, in 62.3% of patients with undetectable plasma viral load cell-associated HIV-RNA could be detected. Analyses of HIV-RNA in plasma and blood cells showed identical sequences in 4/19 patients, whereas the majority of patients had differing HIV-1 RNA sequences in plasma and cells, respectively. In summary, this study shows that residual viral replication in peripheral blood still occurs in the majority of patients with undetectable plasma viral load. Since these replication events could lead to ongoing viral evolution it should be considered to optimize antiretroviral therapy in order to minimize the development of drug resistance. J. Med. Virol. 79:1440-1445, 2007. © Wiley-Liss, Inc.
Bibliography:http://dx.doi.org/10.1002/jmv.20993
istex:44BCD988D0B2AD5AA4834CCBD743942CB8E6DAC0
ArticleID:JMV20993
Deutsche Forschungsgemeinschaft (German Research Foundation) - No. DFGHO 1582/1-3; No. KA1569/1-3
Bundesministerium für Billdung und Forschung (Federal Ministry of Education and Research) - No. BMBF 0312708F
ark:/67375/WNG-8M1MKLFD-W
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.20993